PERSONAL INFORMATION
Name: Cai Ying
Gender: Female
Title: Ph.D
Position: Associate Professor
CONTACT INFORMATION
Email: caiying@cqmu.edu.cn
Address: 1 Yixueyuan Road, Yuzhong District, Chongqing 400016, P.R.China
Phone: +86-15923330181
EDUCATION EXPERIENCE
2016.09- 2019.07 Chongqing Medical University, Chongqing, China
Specialty: Hepatology
Obtained a Doctor Degree of Internal medicine
2010.09-2013.07 Chongqing Medical University, Chongqing, China
Specialty: Nephrology
Obtained a Master Degree of Internal medicine
2002.09-2007.07 Chongqing Medical University, Chongqing, China
Obtained a Bachelor Degree of Clinical Medicine
WORKING EXPERIENCE
2023.04-present School of Nursing, Chongqing Medical University, Chongqing, China (Associate professor/ master supervisor)
2019.08-2022.08 Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China (PostDoctor)
2013.07- 2023.04 Department of Intensive Care Medicine, the Second affiliated hospital of Chongqing Medical University, Chongqing, China (Attending physician of internal medicine)
2007.07-2010.09 Department of Nephrology, the Second affiliated hospital of Chongqing Medical University, Chongqing, China
RESEARCH INTEREST
Precision nursing and nursing cross research
Epigenetics，DNA damage and immunotherapy targets in HCC
HONOUR & AWARDS
Ying Cai, Dina Liu, Jing Cui, Yu Sha, Hengyu Zhou, Ni Tang, Na Wang*, Ailong Huang, Jie Xia*. Diagnostic performance of red blood cell distribution width to platelet ratio for predicting staging liver fibrosis in chronic liver disease patients, Suzhou, China：The 10th National Conference on Difficult and Severe Liver Diseases, 2019. (Outstanding Paper Award)
Ying Cai, Jie Xia, Na Wang, Hengyu Zhou. Identification of prognostic alternative splicing signatures in hepatitis B or/and C viruses related hepatocellular carcinoma. Guangzhou, China：Chinese Cancer Markers Academic Congress, 2020. (Outstanding Paper Award)
PUBLICATIONS
[1] Hong WF#, Gu YJ#, Wang N#, Xia J, Zhou HY, Zhan K, Cheng MX, Cai Y*. Integrative Characterization of Immune-Relevant Genes in Hepatocellular Carcinoma, Journal of Clinical and Translational Hepatology. 2021;9(3):301-314.
[2] Cai Y, Xia J, Wang N, Zhou H. Identification of prognostic alternative splicing signatures in hepatitis B or/and C viruses related hepatocellular carcinoma. Genomics. 2020;112(5):3396-3406.
[3] Liao S#, Zhan K#, Gan L#, Bai Y#, Li J, Yuan G, Cai Y, Zhang A*, He S*, Mei Z*. Inflammatory cytokines, T lymphocyte subsets, and ritonavir involved in liver injury of COVID-19 patients. Signal Transduction and Targeted Therapy. 2020;5(1):255.
[4] Zhou H#, Cai Y#, Liu D, Li M, Sha Y, Zhang W, Wang K, Gong J, Tang N, Huang A*, Xia J*. Pharmacological or transcriptional inhibition of both HDAC1 and 2 leads to cell cycle blockage and apoptosis via p21Waf1/Cip1 and p19INK4d upregulation in hepatocellular carcinoma. Cell Proliferation, 2018 Jun;51(3): e12447.
[5] Cai Y, Liu D, Cui J, Sha Y, Zhou H, Tang N, Wang N*, Huang A, Xia J*. Diagnostic accuracy of red blood cell distribution width to platelet ratio for predicting staging liver fibrosis in chronic liver disease patients: a systematic review and meta-analysis. Medicine (Baltimore), 2019 Apr;98(14): e15096.
[6] Zhang A#, Cai Y#, Wang PF, Qu JN, Luo ZC, Chen XD, Huang B, Liu Y, Huang WQ, Wu J, Yin YH*. Diagnosis and prognosis of neutrophil gelatinase-associated lipocalin for acute kidney injury with sepsis: a systematic review and meta-analysis. Critical care, 2016. 20: p. 41. (IF:5.36)
[7] Cai Y, Tang L. Rare acute kidney injury secondary to hypothyroidism-induced rhabdomyolysis. Yonsei medical journal, 2013. 54(1): p. 172-6.
UNDERTAKING PROJECTS
China Postdoctoral Science Foundation (NO. 2019M663445)
Chongqing Postdoctoral Research Project Special Funding（NO. 2010010005198763）
Chongqing Postdoctoral Natural Science Foundation（NO. cstc2021jcyj-bshX0118）
Science and technology research project of Chongqing Education Commission（NO. KJQN202300451）
